Black Diamond Therapeutics (BDTX) Change in Cash (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Change in Cash of $9.1 million for Q1 2026, up 192.01% on a QoQ basis from -$9.9 million in Q4 2025, and down 85.35% year-over-year from $62.0 million in Q1 2025.
Black Diamond Therapeutics (BDTX) Change in Cash (2019 - 2026) Analysis & Trends
Black Diamond Therapeutics' Change in Cash history runs 8 years deep, the most recent figure standing at $9.1 million for Q1 2026.
- Quarterly Change in Cash fell 85.35% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$68.3 million (down 193.62% YoY) and the FY2025 annual result came in at -$15.4 million, up 21.99% from the prior year.
- Change in Cash was $9.1 million for Q1 2026 at Black Diamond Therapeutics, up from -$9.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $62.0 million in Q1 2025 and bottomed at -$68.4 million in Q2 2025.
- A 5-year average of -$2.1 million and a median of $874000.0 in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash surged 918.0% — and 2025, when it slumped 1025.7%.
- Black Diamond Therapeutics' Change in Cash stood at -$19.6 million in 2022, then soared by 91.08% to -$1.8 million in 2023, then surged by 841.87% to $13.0 million in 2024, then tumbled by 175.91% to -$9.9 million in 2025, then surged by 192.01% to $9.1 million in 2026.
- Business Quant data shows BDTX's Change in Cash at $9.1 million in Q1 2026, -$9.9 million in Q4 2025, and $874000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.08 Mn |
| Dec 31, 2025 | -9.87 Mn |
| Sep 30, 2025 | 874,000.00 |
| Jun 30, 2025 | -68.43 Mn |
| Mar 31, 2025 | 61.99 Mn |
| Dec 31, 2024 | 13.01 Mn |
| Sep 30, 2024 | -9.38 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | -30.80 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Sep 30, 2023 | 15.68 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | -19.65 Mn |
| Sep 30, 2022 | -1.92 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | -11.72 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Sep 30, 2021 | 9.28 Mn |
| Jun 30, 2021 | 23.22 Mn |